Clinical trial
Confirmatory Study on the Acute Effects of Zynamite® S on Cognitive Function and Mood in University Students: a Randomized, Double-blind, Placebo-controlled Crossover Study
NCT07126717 is registered in ClinicalTrials.gov with Nektium Pharma SL as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Confirmatory Study on the Acute Effects of Zynamite® S on Cognitive Function and Mood in University Students: a Randomized, Double-blind, Placebo-controlled Crossover Study
- Lead sponsor
- Nektium Pharma SL
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 12, 2025
- Completion date
- June 9, 2025
- Enrollment
- 88 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive performance, mood